Open AccessIdentifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis During Preventive Care and Reproductive Visits in Adolescents in the Deep South
Author(s) -
Samantha V. Hill,
Andrew O. Westfall,
Tamera CoyneBeasley,
Tina Simpson,
Latesha Elopre
Publication year - 2019
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001104
Subject(s) - medicine , pre exposure prophylaxis , polysubstance dependence , young adult , human immunodeficiency virus (hiv) , cross sectional study , family medicine , pediatrics , men who have sex with men , substance abuse , gerontology , psychiatry , syphilis , pathology
Pre-exposure prophylaxis (PrEP) for individuals at significant risk for Human Immunodeficiency Virus acquisition is approved for individuals weighing at least 35 kg by the Food and Drug Administration. This cross-sectional study analyzed indications for PrEP in a clinical setting.